Effects of withdrawal from an escalating dose of amphetamine on conditioned fear and dopamine response in the medial prefrontal cortex

Behavioural Brain Research

Volumn 186, Issue 1, 2008, Pages 12-22

  Peleg Raibstein, D ^a   Feldon, J ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Amphetamine; Microdialysis; Rats; Schizophrenia; Sensitization; Withdrawal

Indexed keywords

AMPHETAMINE; DOPAMINE; SODIUM CHLORIDE;

AVERSION; DOPAMINERGIC SYSTEM; DRUG DOSE ESCALATION; DRUG WITHDRAWAL; FEAR; HABITUATION; HUMAN; IN VIVO STUDY; LOCOMOTION; MICRODIALYSIS; NERVE PROJECTION; NEUROCHEMISTRY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SENSITIZATION;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; ASSOCIATION LEARNING; CONDITIONING, CLASSICAL; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEAR; MALE; MICRODIALYSIS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 36048950688     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.07.034     Document Type: Review

References (44)

1. Abercrombie E.D., Keefe K.A., DiFrischia D.S., and Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 52 (1989) 1655-1658
2. Abi-Dargham A., Gil R., Krystal J., Baldwin R.M., Seibyl J.P., Bowers M., et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155 (1998) 761-767
3. Antelman S.M., Eichler A.J., Black C.A., and Kocan D. Interchangeability of stress and amphetamine in sensitization. Science 207 (1980) 329-331
4. Bebbington P., Wilkins S., Jones P., Foerster A., Murray R., Toone B., et al. Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study. Br J Psychiatry 162 (1993) 72-79
5. Davis K.L., Kahn R.S., Ko G., and Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148 (1991) 1474-1486
6. Deutch A.Y., and Roth R.H. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res 85 (1990) 367-402
7. Feenstra M.G. Dopamine and noradrenaline release in the prefrontal cortex in relation to unconditioned and conditioned stress and reward. Prog Brain Res 126 (2000) 133-163
8. Feenstra M.G., Botterblom M.H., and Mastenbroek S. Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: effects of novelty and handling and comparison to the nucleus accumbens. Neuroscience 100 (2000) 741-748
9. Feenstra M.G., Botterblom M.H., and van Uum J.F. Novelty-induced increase in dopamine release in the rat prefrontal cortex in vivo: inhibition by diazepam. Neurosci Lett 189 (1995) 81-84
10. Feenstra M.G., Teske G., Botterblom M.H., and De Bruin J.P. Dopamine and noradrenaline release in the prefrontal cortex of rats during classical aversive and appetitive conditioning to a contextual stimulus: interference by novelty effects. Neurosci Lett 272 (1999) 179-182
11. Feenstra M.G., Vogel M., Botterblom M.H., Joosten R.N., and de Bruin J.P. Dopamine and noradrenaline efflux in the rat prefrontal cortex after classical aversive conditioning to an auditory cue. Eur J Neurosci 13 (2001) 1051-1054
12. Finlay J.M., and Zigmond M.J. The effects of stress on central dopaminergic neurons: possible clinical implications. Neurochem Res 22 (1997) 1387-1394
13. Goldstein L.E., Rasmusson A.M., Bunney B.S., and Roth R.H. The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat. J Neurosci 14 (1994) 4937-4950
14. Goldstein L.E., Rasmusson A.M., Bunney B.S., and Roth R.H. Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci 16 (1996) 4787-4798
15. Hamamura T., and Fibiger H.C. Enhanced stress-induced dopamine release in the prefrontal cortex of amphetamine-sensitized rats. Eur J Pharmacol 237 (1993) 65-71
16. Inoue T., Tsuchiya K., and Koyama T. Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmacol Biochem Behav 49 (1994) 911-920
17. Kalivas P.W., Sorg B.A., and Hooks M.S. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 4 (1993) 315-334
18. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16 (1991) 223-244
19. Kolta M.G., Shreve P., De Souza V., and Uretsky N.J. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology 24 (1985) 823-829
20. Kuczenski R., Segal D.S., and Todd P.K. Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments. Psychopharmacology (Berlin) 134 (1997) 221-229
21. Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Brain Res Rev 31 (2000) 371-384
22. Laruelle M., Abi-Dargham A., Gil R., Kegeles L., and Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46 (1999) 56-72
23. Lin D., Koob G.F., and Markou A. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat-interactions between the two drugs. Psychopharmacology (Berlin) 145 (1999) 283-294
24. Mingote S., de Bruin J.P., and Feenstra M.G. Noradrenaline and dopamine efflux in the prefrontal cortex in relation to appetitive classical conditioning. J Neurosci 24 (2004) 2475-2480
25. Murphy C.A., Fend M., Russig H., and Feldon J. Latent inhibition, but not prepulse inhibition, is reduced during withdrawal from an escalating dosage schedule of amphetamine. Behav Neurosci 115 (2001) 1247-1256
26. Nader K., and LeDoux J.E. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behav Neurosci 113 (1999) 891-901
27. Norman R.M., and Malla A.K. Stressful life events and schizophrenia. I: a review of the research. Br J Psychiatry 162 (1993) 161-166
28. Paulson P.E., and Robinson T.E. Regional differences in the effects of amphetamine withdrawal on dopamine dynamics in the striatum. Analysis of circadian patterns using automated on-line microdialysis. Neuropsychopharmacology 14 (1996) 325-337
29. Peleg-Raibstein D., Sydekum E., and Feldon J. Differential effects on prepulse inhibition of withdrawal from two different repeated administration schedules of amphetamine. Int J Neuropsychopharmacol (2006) 1-13
30. Pezze M.A., Feldon J., and Murphy C.A. Increased conditioned fear response and altered balance of dopamine in the shell and core of the nucleus accumbens during amphetamine withdrawal. Neuropharmacology 42 (2002) 633-643
31. Richmond M.A., Murphy C.A., Pouzet B., Schmid P., Rawlins J.N., and Feldon J. A computer controlled analysis of freezing behaviour. J Neurosci Methods 86 (1998) 91-99
32. Robinson T.E., and Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396 (1986) 157-198
33. Russig H., Murphy C.A., and Feldon J. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal. Neuropsychopharmacology 26 (2002) 765-777
34. Russig H., Murphy C.A., and Feldon J. Behavioural consequences of withdrawal from three different administration schedules of amphetamine. Behav Brain Res 165 (2005) 26-35
35. Segal D.S., and Kuczenski R. An escalating dose binge model of amphetamine psychosis: behavioral and neurochemical characteristics. J Neurosci 17 (1997) 2551-2566
36. Snyder S.H. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am J Psychiatry 133 (1976) 197-202
37. Sorg B.A., and Kalivas P.W. Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience 53 (1993) 695-703
38. Steketee J.D. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res Brain Res Rev 41 (2003) 203-228
39. Tzschentke T.M., and Schmidt W.J. Differential effects of discrete subarea-specific lesions of the rat medial prefrontal cortex on amphetamine- and cocaine-induced behavioural sensitization. Cereb Cortex 10 (2000) 488-498
40. van der Meulen J.A., Joosten R.N., de Bruin J.P., and Feenstra M.G. Dopamine and noradrenaline efflux in the medial prefrontal cortex during serial reversals and extinction of instrumental goal-directed behavior. Cereb Cortex 17 6 (2007) 1444-1453
41. Wilkinson L.S., Humby T., Killcross A.S., Torres E.M., Everitt B.J., and Robbins T.W. Dissociations in dopamine release in medial prefrontal cortex and ventral striatum during the acquisition and extinction of classical aversive conditioning in the rat. Eur J Neurosci 10 (1998) 1019-1026
42. Yoshioka M., Matsumoto M., Togashi H., and Saito H. Effect of conditioned fear stress on dopamine release in the rat prefrontal cortex. Neurosci Lett 209 (1996) 201-203
43. Li Y., and Wolf M.E. Ibotenic acid lesions of prefrontal cortex do not prevent expression of behavioral sensitization to amphetamine. Behav Brain Res 84 1-2 (1997) 285-289
44. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press